Tempest Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-5.71-4.29-4.61-9.86
Price/Sales ratio
N/A3.541.092.50
Earnings per Share (EPS)
$-1.60$-2.13$-1.98$-0.93

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-20.22-3.61-0.59-0.00-0.45-2.07-0.05-0.67-0.36-2.30-0.75-2.07
Price/Sales ratio
102.87955.3075.321.24N/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
18.102.080.450.160.171.57-0.010.550.732.532.210.17
Price/Cash Flow ratio
-32.74-5.26-0.79-0.01-0.52-2.24-0.05-0.77-0.42-2.47-5.63-2.24
Price/Free Cash Flow ratio
-29.99-4.76-0.76-0.01-0.51-2.21-0.05-0.76-0.41-2.46-60.71-2.21
Price/Earnings Growth ratio
-0.28-0.150.11N/A0.000.02-0.000.000.000.05-0.030.02
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%-711.91%-727.10%90.50%N/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
-492.37%-25992.41%-11579.17%-6943.05%N/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
-508.68%-26405.77%-12566.46%-28673.22%N/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
-508.68%-26432.85%-12597.24%-28670.50%N/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
3.20%-0.10%-0.24%-0.07%0.62%-0.00%0.46%-4.40%-2.99%N/AN/AN/A
Return on Assets
-75.52%-52.82%-67.12%-426.90%-32.34%-59.44%-83.61%-40.34%-79.79%-57.14%-115.79%-59.44%
Return On Equity
-89.50%-57.72%-76.01%-3796.14%-38.32%-76.12%27.79%-81.81%-203.07%-110.17%-195.53%-76.12%
Return on Capital Employed
-86.52%-56.52%-69.15%-130.28%-31.12%-72.69%-98.25%-50.71%-89.25%-69.10%-132.88%-72.69%
Liquidity Ratios
Current Ratio
6.0811.558.818.818.495.685.12N/AN/AN/A4.525.68
Quick Ratio
6.0811.558.814.828.495.685.943.364.524.284.295.68
Cash ratio
0.633.863.324.307.465.075.842.584.294.164.295.07
Days of Sales Outstanding
N/AN/AN/A1.27KN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/A0.01N/AN/A307.22454.38N/AN/AN/AN/A
Operating Cycle
N/AN/AN/A1.27KN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/A544.01147.5216.92K22.78K518.70479.65284.81222.94809.51N/A518.70
Cash Conversion Cycle
N/A-544.01-147.52-15.64KN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/A0.030.000.02N/A0.220.250.220.600.00
Debt Equity Ratio
N/AN/AN/A0.340.000.03N/A0.450.650.421.540.00
Long-term Debt to Capitalization
N/AN/AN/A0.210.00N/AN/A0.290.360.180.360.00
Total Debt to Capitalization
N/AN/AN/A0.250.000.03N/A0.310.390.300.390.00
Interest Coverage Ratio
N/AN/AN/AN/A-200.5543.73N/AN/AN/AN/A-21.35-200.55
Cash Flow to Debt Ratio
N/AN/AN/A-26.31-41.34-21.04N/A-1.57-2.63-2.37-0.60-41.34
Company Equity Multiplier
1.181.091.138.891.181.28-0.332.022.541.922.541.18
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-3.14-181.53-94.53-68.94N/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.091.101.041.001.001.001.001.001.011.000.091.00
Cash Flow Coverage Ratio
N/AN/AN/A-26.31-41.34-21.04N/A-1.57-2.63-2.37-0.60-41.34
Short Term Coverage Ratio
N/AN/AN/A-116.89-125.11-21.04N/A-18.00-21.99-5.22-5.02-125.11
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A